| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/24/2006 | US20060188963 Collectin-complement activating protein chimeras |
| 08/24/2006 | US20060188962 19 human secreted proteins |
| 08/24/2006 | US20060188959 Crystal structure of worm NitFhit reveals that a Nit tetramer binds tow Fhit dimers |
| 08/24/2006 | US20060188957 Novel TNF receptor death domain ligand proteins and inhibitors of ligand binding |
| 08/24/2006 | US20060188933 IRAK-M is a negative regulator of toll-like receptor signaling |
| 08/24/2006 | US20060188925 polynucleotides that encoding a cytotoxic T-lymphocyte associated protien-4 (CTLA-4) receptor, used as vaccines |
| 08/24/2006 | US20060188924 TCL-1 gene and protein and related methods and compositions |
| 08/24/2006 | US20060188913 Methods and products for enhancing immune responses using imidazoquinoline compounds |
| 08/24/2006 | US20060188577 Element having bioactive substance fixed thereto |
| 08/24/2006 | US20060188561 Pharmaceutical compositions for lipophilic drugs |
| 08/24/2006 | US20060188560 Delivery system for nucleic acids |
| 08/24/2006 | US20060188556 Ultrasonically assisted dermal or transdermal delivery substance preparation |
| 08/24/2006 | US20060188555 Therapeutic peptide formulations with improved stability |
| 08/24/2006 | US20060188534 Dispersions for the formulation of slightly or poorly soluble agents |
| 08/24/2006 | US20060188525 Relieving spastic muscle pain; ultrasonic frequency disruption of stratum corneum and applying patch containing neurotoxin |
| 08/24/2006 | US20060188524 Canine vaccine for protection against ehrlichiosis |
| 08/24/2006 | US20060188521 Disrupting sex steroid signal to thymus: bone marrow or hematopoietic cells |
| 08/24/2006 | US20060188516 Chlamydia trachomatis antigens |
| 08/24/2006 | US20060188513 Novel inhibin-related multiple antigenic peptide compositions that enhance production performance in avians |
| 08/24/2006 | US20060188512 Active immunization to generate antibodies to solble a-beta |
| 08/24/2006 | US20060188506 Therapy-enhancing glucan |
| 08/24/2006 | US20060188503 Modulation of eNOS activity and therapeutic uses thereof |
| 08/24/2006 | US20060188501 Diagnostic and therapeutic agents for rheumatoid arthritis |
| 08/24/2006 | US20060188498 Methods of using death receptor agonists and EGFR inhibitors |
| 08/24/2006 | US20060188497 Immunotherapeutic combination for the treatment of tumors that over-express receptors with tyrosine kinase activity |
| 08/24/2006 | US20060188496 Intranasal administration of active agents to the central nervous system |
| 08/24/2006 | US20060188492 Topical management of ocular and periocular conditions |
| 08/24/2006 | US20060188491 Use of nuclear material to therapeutically reprogram differentiated cells |
| 08/24/2006 | US20060188485 Autologous self-tolerance inducing cells of monocytic origin and their use in pharmaceutical preparations |
| 08/24/2006 | US20060188484 Virus vectors and methods of making and administering the same |
| 08/24/2006 | US20060188483 Virus vectors and methods of making and administering the same |
| 08/24/2006 | US20060188480 Viral vectors |
| 08/24/2006 | US20060188478 Glycosylated interferon |
| 08/24/2006 | US20060188477 Use of interferon alpha 5 in the treatment of viral liver diseases |
| 08/24/2006 | US20060188476 Interleukin 20 (IL-20) and its use in neovascularisation |
| 08/24/2006 | US20060188475 Methods and compositions using immunomodulatory compounds for the treatment of immunodeficiency disorders |
| 08/24/2006 | US20060188474 Interleukin 1beta protease and interleukin 1beta protease inhibitors |
| 08/24/2006 | US20060188473 Compositions and methods for repressing B cell autoantibody secretion and for treating autoimmune disorders |
| 08/24/2006 | US20060188472 HAS-active ingredient conjugates |
| 08/24/2006 | US20060188471 Methods of treating epithelial lesions |
| 08/24/2006 | US20060188446 T-cell epitope peptides |
| 08/24/2006 | US20060188437 Isolation of a cell-specific internalizing peptide that infiltrates tumor tissue for targeted drug delivery |
| 08/24/2006 | DE60115613T2 Herstellung von rekombinanten muteine des blutgerinnungsfaktors viii in humanen zellinien Production of recombinant muteins of the blood coagulation factor viii in human cell lines |
| 08/24/2006 | CA2614068A1 Methods and compositions related to the modulation of intercellular junctions |
| 08/24/2006 | CA2599566A1 Insulin-like growth factor binding protein-4 compounds and methods for inhibiting angiogenesis and tumor growth in mammalian cells |
| 08/24/2006 | CA2598570A1 Methods for producing proteins using hamster igf-1 |
| 08/24/2006 | CA2598448A1 Antiangiogenic agents with aldesleukin |
| 08/24/2006 | CA2598360A1 Template-fixed beta-hairpin peptidomimetics with protease inhibitory activity |
| 08/24/2006 | CA2598292A1 Poly-epitope peptide derived from thymidylate synthase having immunological and anti-tumour activity |
| 08/24/2006 | CA2598121A1 Highly potent full and partial agonists and antagonists of the nociceptin/orphanin fq receptor |
| 08/24/2006 | CA2598080A1 Amyloid-binding peptides, analogues and uses thereof |
| 08/24/2006 | CA2598044A1 Cosmetic use of at least one natural ac-n-ser-asp-lys-pro-tetrapeptide or one of its analogues as agent for slowing down loss of hair and/or stimulating hair growth |
| 08/24/2006 | CA2597933A1 Methods for treating lymphomas using a combination of a chemotherapeutic agent and il-2 and optionally an anti-cd20 antibody |
| 08/24/2006 | CA2597932A1 Detection of biomarkers for neuropsychiatric disorders |
| 08/24/2006 | CA2597931A1 Apparatus and method for transdermal delivery of erythropoetin-based agents |
| 08/24/2006 | CA2597925A1 Use of human hemojuvelin product to regulate hepcidin-mediated iron metabolism |
| 08/24/2006 | CA2597795A1 A molecule and chimeric molecules thereof |
| 08/24/2006 | CA2597627A1 Modulation of muc1 activity |
| 08/24/2006 | CA2597584A1 Molecules and chimeric molecules thereof |
| 08/24/2006 | CA2597367A1 Glucose oxidase formulations and methods for making and using them |
| 08/24/2006 | CA2596986A1 Use of il-17f in diagnosis and therapy of airway inflammation |
| 08/24/2006 | CA2596673A1 Stabilized compositions containing natriuretic peptides |
| 08/24/2006 | CA2596664A1 Combination therapy with glatiramer acetate and rasagiline for the treatment of multiple sclerosis |
| 08/24/2006 | CA2596509A1 Interleukin-17f antibodies and other il-17f signaling antagonists and uses therefor |
| 08/24/2006 | CA2595931A1 Methods of using death receptor agonists and egfr inhibitors |
| 08/24/2006 | CA2595581A1 Sustained release composition of protein drug |
| 08/24/2006 | CA2595368A1 Use of calcitonin and calcitonin-like peptides to treat and prevent multiple sclerosis |
| 08/24/2006 | CA2594490A1 Methods of treating skin disorders using an il-31ra antagonist |
| 08/23/2006 | EP1693459A1 Chimeric type 5/type 11 or type 35 adenovirus vector for preventing infection with antihuman immunodeficiency virus |
| 08/23/2006 | EP1693457A2 Metastatic breast and colon cancer regulated genes |
| 08/23/2006 | EP1693456A1 Gene encoding g protein-coupled receptor and gene product thereof |
| 08/23/2006 | EP1693384A2 Functional immunoglobulins against human serum albumin, fragments thereof, library thereof and methods of production thereof |
| 08/23/2006 | EP1693382A2 Melanocortin 1 receptor selective compounds |
| 08/23/2006 | EP1693381A1 Glycine-rich proteins, their coding sequences and applications |
| 08/23/2006 | EP1693073A2 Wound dressings comprising hydrated hydrogels and enzymes |
| 08/23/2006 | EP1693068A1 Use of M. tuberculosis chaperonin 60.1 for the treatment of arthritis |
| 08/23/2006 | EP1693065A1 Fibroblast-mobilizing agent containing g-csf and wound remedy |
| 08/23/2006 | EP1692522A1 A reference solution |
| 08/23/2006 | EP1692504A1 Solution-based methods for detecting mhc-binding peptides |
| 08/23/2006 | EP1692287A1 Bacterial virulence factors and uses thereof |
| 08/23/2006 | EP1692276A2 Method of inducing memory b cell development and terminal differentiation |
| 08/23/2006 | EP1692267A2 Methods of organ regeneration |
| 08/23/2006 | EP1692265A2 Method of preventing virus: cell fusion by inhibiting the function of the fusion initiation region in rna viruses having class i membrane fusogenic envelope proteins |
| 08/23/2006 | EP1692260A2 Hypoxia - responsive human cngh-0002 genes and polypeptides |
| 08/23/2006 | EP1692187A1 Ec sod and cell transducing ec sod and use thereof |
| 08/23/2006 | EP1692186A1 Cancer cell targeting gene delivery method |
| 08/23/2006 | EP1692180A2 Anti-il-20 antibodies and binding partners and methods of using in inflammation |
| 08/23/2006 | EP1692178A1 Methods and compositions for inhibiting c-met dimerization and activation |
| 08/23/2006 | EP1692175A2 Compositions and methods for regulation of tumor necrosis factor-alpha |
| 08/23/2006 | EP1692173A2 Protein from horn fly saliva that disrupts hemostasis |
| 08/23/2006 | EP1692168A1 Single-chain insulin |
| 08/23/2006 | EP1692167A2 Mutant lrp5/6 wnt-signaling receptors in cancer diagnosis, prognosis and treatment |
| 08/23/2006 | EP1692166A1 Novel muscle growth regulator |
| 08/23/2006 | EP1692160A2 Fgf-5 binding and supported peptides |
| 08/23/2006 | EP1692159A2 Tgf-beta binding and supported peptides |
| 08/23/2006 | EP1692158A2 Tgf-beta binding and supported peptides |
| 08/23/2006 | EP1692157A2 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 08/23/2006 | EP1692154A1 Reduction of dermal scarring |
| 08/23/2006 | EP1692104A1 Methods of preparing compounds useful as protease inhibitors |
| 08/23/2006 | EP1691891A2 Inhibition of trp channels as a treatment for cardiac hypertrophy and heart failure |